Health
U.S. to pay $1 billion for 100 million doses of Johnson & Johnson’s COVID-19 vaccine candidate – Investing.com
U.S. to pay $1 billion for 100 million doses of Johnson & Johnson’s COVID-19 vaccine candidate
By Michael Erman
(Reuters) – The United States government will pay Johnson & Johnson (N:JNJ) over $1 billion for 100 million doses of its potential coronavirus vaccine, as it stocks up on vaccine and drugs in an attempt to tame the pandemic.
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March. That compares with the $19.50 per …
-
Noosa News19 hours agoDangerous storm pounds south-east Queensland with giant hail, blackouts and widespread damage
-
Noosa News22 hours agoBruce Highway fatal: Grandmother’s heartbreak as daughter and granddaughter killed in Queensland truck crash
-
General6 hours agoVictorian government blocked fire service from pursuing US giant over PFAS contamination
-
Business22 hours agoWhy Gentrack, Monash IVF, Pro Medicus, and Qube shares are racing higher today